871 / 1851
Positive prognostic role of MGMT methylation
•
Median OS: 18.2 vs 12.2 months
Hegi M. et al. NEJM 2005;352
Overall, MGMT promoter
methylated in 45% of patients
MGMT promoter was an
independent favorable prognostic
factor, irrespective of treatment.